Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis

BACKGROUND: Despite enormous efforts to combat malaria the disease still afflicts up to half a billion people each year of which more than one million die. Currently no approved vaccine is available and resistances to antimalarials are widely spread. Hence, new antimalarial drugs are urgently needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Huthmacher, Carola, Hoppe, Andreas, Bulik, Sascha, Holzhütter, Hermann-Georg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941759/
https://www.ncbi.nlm.nih.gov/pubmed/20807400
http://dx.doi.org/10.1186/1752-0509-4-120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941759/
https://www.ncbi.nlm.nih.gov/pubmed/20807400
http://dx.doi.org/10.1186/1752-0509-4-120

Ejemplares similares